Results 151 to 160 of about 361,079 (214)

Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities. [PDF]

Open Forum Infect Dis
Feemster K, Buchwald UK, Banniettis N, Joyce JG, Velentgas P, Chapman TJ, Yildirim I.   +6 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in Germany. [PDF]

Vaccines (Basel)
Huang M, Weaver JP, Elbasha E, Weiss T, Banniettis N, Feemster K, White M, Kelly MS.   +7 more
europepmc   +1 more source

Burden of Pneumococcal Disease in Young Children Due to Serotypes Contained in Different Pneumococcal Conjugate Vaccines in Eight Asian Countries and Territories. [PDF]

Vaccines (Basel)
Huang L, Li X, Eugenia N, Leung J, Hung SA, Cheong EZB, Avila R, Nua W, Choowanich K, Rampal R, Kulkarni N, Daigle D, Taysi BN.   +12 more
europepmc   +1 more source

Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis. [PDF]

Lancet Infect Dis
Bennett JC, Deloria Knoll M, Kagucia EW, Garcia Quesada M, Zeger SL, Hetrich MK, Yang Y, Herbert C, Ogyu A, Cohen AL, Yildirim I, Winje BA, von Gottberg A, Viriot D, van der Linden M, Valentiner-Branth P, Suga S, Steens A, Skoczynska A, Sinkovec Zorko N, Scott JA, Savulescu C, Savrasova L, Sanz JC, Russell F, Ricketson LJ, Puentes R, Nuorti JP, Mereckiene J, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, MacDonald L, Lepp T, Ladhani SN, Kristinsson KG, Kozakova J, Klein NP, Jayasinghe S, Ho PL, Hilty M, Heyderman RS, Hasanuzzaman M, Hammitt LL, Guevara M, Grgic-Vitek M, Gierke R, Georgakopoulou T, Galloway Y, Diawara I, Desmet S, De Wals P, Dagan R, Colzani E, Cohen C, Ciruela P, Chuluunbat U, Chan G, Camilli R, Bruce MG, Brandileone MC, Bigogo G, Ampofo K, O'Brien KL, Feikin DR, Hayford K, PSERENADE Team.   +67 more
europepmc   +1 more source

Correction to: Immunogenicity of Current and Next-Generation Pneumococcal Conjugate Vaccines in Children: Current Challenges and Upcoming Opportunities. [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pneumococcal conjugate vaccines

Immunology Letters, 1991
We have prepared conjugates of pneumococcal type 4 polysaccharides (PS4) or oligosaccharides to tetanus toxoid using the carbodiimide method. The use of a spacer, 6-aminohexanoic acid, resulted in higher incorporation of carrier protein. Conjugates contained up to 10% free polysaccharide, but no free protein.
C C, Peeters, A M, Tenbergen-Meekes, B, Haagmans, D, Evenberg, J T, Poolman, B J, Zegers, G T, Rijkers   +6 more
openaire   +4 more sources

Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis [PDF]

New England Journal of Medicine, 2009
Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine (PCV7) in 2000, but its effect on pneumococcal meningitis is unclear.We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population-based surveillance data from eight sites in
William Schaffner, Heather Hsu, Ann Thomas   +2 more
exaly   +3 more sources